Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis

NCT04353791 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis Chronic Moderate
Ulcerative Colitis Chronic Severe

Interventions

DRUG: OST-122
DRUG: Placebo

Sponsor

Oncostellae S.L